Mapping the heart’s cellular blueprint: New insights into cardiac structure and disease repair

MPM BioIm­pact and No­vo Hold­ings are among a group of in­vestors pour­ing $103 mil­lion in­to a psy­che­del­ic biotech that MPM took pri­vate last sum­mer. Re­union

CHICA­GO — Özlem Türe­ci took a sev­en-year break from at­tend­ing the Amer­i­can So­ci­ety of Clin­i­cal On­col­o­gy’s an­nu­al meet­ing. She’d been busy with the Covid-19 pan­dem­ic